Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.

Key Takeaway: Merck has initiated a tender offer to acquire Terns Pharmaceuticals, Inc. This strategic move is part of Merck's ongoing efforts to expand its portfolio and enhance its capabilities in the biopharmaceutical sector. The acquisition reflects Merck's commitment to growth through strategic partnerships and investments.